Expert Interviews

March 02, 2021

Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021.

December 21, 2020

Experts in diabetes provide their perspective on various facets of diabetes management including the use of insulin pumps.

December 14, 2020

Learn why one organization prioritizes screening for diabetic retinopathy among patients with diabetes.

December 14, 2020

A discussion centered around optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.

November 27, 2020

Jeffrey Curtis, MD, MS, MPH, details how the perception of biphosphonates has been detrimental to efforts to improve treatment and diagnosis of osteoporosis.

November 24, 2020

An endocrinologist from Brigham and Women’s Hospital discusses the latest in diabetes management.

November 24, 2020

Jeffrey Curtis, MD, MS, MPH, offers his thoughts on the most effective methods to address the underdiagnosis and undertreatment of osteoporosis in older male patients.

November 18, 2020

A cardiologist from Brigham and Women's Hospital offers his thoughts on the results of phase 3 SCORED and SOLOIST trials, which examined use of sotagliflozin in patients with type 2 diabetes.

November 16, 2020

Professor John McMurray explains why he is not as displeased as some colleagues are with the uptake of SGLT2 inhibitor prescribing rates for patients with heart failure or chronic kidney disease.

November 14, 2020

In honor of World Diabetes Day, we reached out to Lucia Novak, CRNP, to get her perspective on the role of nurses in the diabetes care model as "The Nurse and Diabetes" has been chosen as the official theme of this year's World Diabetes Day.